Lobular Breast Cancer Alliance (LBCA)
@lobularbca
LBCA is the only organization in the US dedicated to invasive lobular carcinoma (ILC) also known as lobular breast cancer, the 2nd most common breast cancer type. Learn more at lobularbreastcancer.org
The Lobular American Research Consortium (LARC), the first investigator-led U.S. research consortium dedicated exclusively to invasive lobular carcinoma (ILC), has officially launched. Learn more about how LARC will accelerate collaboration and advance research: bit.ly/4yWXRtR #ILC
LBCA Scientific Advisory Board member Dr. George Sflomos recently shared insights into his research on LOX inhibition and its role in disrupting pathways involved in the progression of metastatic ILC tumors, as well as what this work may mean for the future research. Learn more: bit.ly/4pFqAPw
LBCA and SNMMI are accepting applications for a $100,000 Invasive Lobular Carcinoma Imaging Research Grant to support innovative #ILC imaging research. Applications are due August 14. Apply here: lnkd.in/e6rhZan3
We're excited to welcome Mary Pat Landry to the LBCA Board of Directors! After her 2022 invasive lobular carcinoma (ILC) diagnosis, Mary Pat found support through LBCA and is now helping advance our mission. Learn more about our Board of Directors: lobularbreastcancer.org/board-of-dir...
A new clinical trial testing efficacy of a drug to treat metastatic ILC is now enrolling. Led by LBCA Scientific Advisory Board Chair Dr. Jason Mouabbi, the IvoLoC Trial will advance knowledge of options for personalized treatment approaches for people living with metastatic ILC. 🔗 bit.ly/4fk9XoY
Join LBCA on Wednesday, July 29 at 3:00 p.m. ET for our third Liquid Biopsy webinar. Hear from leading experts on the latest research and what's next. Register: us02web.zoom.us/webinar/regi... #lobularbreastcancer #invasivelobularcarcinoma #ILC
This month we show our gratitude to LBCA Board of Directors member, Irene Jamieson, for her generous donation of this year’s volunteer appreciation gift. Irene has been a valuable, longtime supporter of LBCA with both her time and gifts and we are so thankful for her continued generosity!
Two LBCA SAB Members made the news, Dr. Ulaner was elected President of SNMMI and Dr. Kruse was interviewed in on clinical trials. lobularbreastcancer.org/sab-members-...
LBCA’s fourth Local Advocacy Team (LAT) has launched in Michigan! It will be run by LAT Ambassadors Valerie Frasier and Ciara Mohan Gustafson. Learn more and about how you can get involved: lobularbreastcancer.org/michigan_LAT/ #lobularbreastcancer #invasivelobularcarcinoma #ILC #LBCALAT
LBCA Patient Advocate Advisory Board member Jade Moran helped put lobular breast cancer front and center at the 2026 SNMMI Annual Meeting: lobularbreastcancer.org/advocacy-in-...
LBCA patient advocate, Jade Moran interviewed SNMMI Mars Shot Awardee Dr. Sutcliffe about her research into new imaging technologies that could improve ILC detection and treatment. lobularbreastcancer.org/new-imaging-...
LBCA is offering a limited number of travel grant scholarships for patient advocates to attend the 2026 San Antonio Breast Cancer Symposium (SABCS26), Dec. 8–11th in TX. Learn more and apply by July 19th: lobularbreastcancer.org/lbca-travel-... #lobularbreastcancer #invasivelobularcarcinoma #ILC
ASCO26 was a historic event for ILC with the first ever session focused on lobular breast cancer seeing standing-room only attendance. Read LBCA ED Laurie Hutcheson's experience: lobularbreastcancer.org/lbca-ed-laur... #lobularbreastcancer #ILC
LBCA Local Advocacy Team (LAT) members Julie Ray and Kathie Nejberger will be patient panelists on an Atrium Health webinar about lobular breast cancer on July 17th. Register here: atriumhealth.org/events/under...
Let us know how we're doing in our feedback survey! Each year LBCA seeks input from our subscribers and followers to help us continue to improve as we seek to eradicate lobular breast cancer. The survey takes 5-10 minutes and closes July 17th: www.surveymonkey.com/r/constituen...
The International ILC Symposium is coming up September 23–25th in San Francisco, and LBCA is a proud sponsor. This is the only scientific conference focused on lobular breast cancer. Register through UCSF: ilcsymposium.com/registration #LobularBreastCancer #InvasiveLobularCarcinoma #ILC
"Myth: “Chemotherapy isn’t effective for lobular breast cancer.” The reality is more nuanced — and the nuance matters for patients.Read LBCA’s full ILC Myths vs. Facts resource: lobularbreastcancer.org/myths-vs-fac... #ILCMythVsFact #LobularBreastCancer #InvasiveLobularCarcinoma #ILC"
Three new clinical trials focused on invasive lobular carcinoma (ILC) are open. Each focuses on new imaging methods to better detect and stage lobular breast cancer improving on current methods which consistently fail ILC patients. lobularbreastcancer.org/new-ilc-clin...
WE MADE HISTORY FOR LOBULAR RESEARCH! Thank you to everyone who supported the Match the $1 Million Challenge and Dr. Klingman for her historic $1 million gift. Together, we're funding research and increasing hope for lobular patients everywhere! #LobularBreastCancer #invasivelobularcarcinoma #ILC
Advocates showed up for lobular at the @ascocancer.bsky.social annual meeting with a visual presence in support of lobular breast cancer advocacy and awareness. #lobularbreastcancer #ILC #invasivelobularcarcinoma #ILCresearch #ASCO26
LBCA made history for lobular breast cancer at the ASCO 2026 with the first education session on ILC! Thank you LBCA SAB Members, Dr. Covington, Jeselsohn and Mukhtar for their excellent presentations. #lobularbreastcancer #ILC #invasivelobularcarcinoma #ILCresearch #ASCO26
Lobular Breast Cancer receives less than 1% of breast cancer research funding, despite being 15% of all breast cancer diagnoses. Dr. Klingman, ILC survivor and OBGYN, gave $1 Million to change that. Help us match it, we’ve raised nearly $250,000! tinyurl.com/LBCAMatchThe...
LBCA has won a 2026 Communicator Award, Nonprofit Social media for the LBCA-Dr. Klingman Lobular Breast Cancer Research Challenge! To join us in the challenge before it ends this month visit: tinyurl.com/LBCAMatchThe... #commawards #LobularBreastCancer #invasivelobularcarcinoma #ILC #ilcresearch
LBCA is offering travel scholarship grants for patient advocates interested in Invasive Lobular Carcinoma (ILC) education and research advocacy to attend the ILC Symposium September 23-25 in San Francisco. To learn more and apply by May 10th visit: lobularbreastcancer.org/lbca-travel-...
In the first LBCA-sponsored lecture at DFCI, Dr. Bahl presented The Roles of 3D Imaging and AI in Improving ILC Detection: lobularbreastcancer.org/dr-bahl-pres...
Research Funding Alert! The LBCA-Shannon Klingman Lobular Breast Cancer Clinical Research Grants provide funding to promote quality research in oncology with a focus on invasive lobular breast cancer. Apply by May 11: bit.ly/4sKTM7L #lobularbreastcancer #invasivelobularcarcinoma #ILC #ILCresearch
This Volunteer Appreciation Month, LBCA emphatically thanks our volunteer community who give their time, talents, passion and energy to help LBCA spread awareness of lobular breast cancer and advance ILC research across the US and around the world. We are thankful for all you do!
We have partnered with Dr. Shannon Klingman, founder of Lume Deodorant and lobular breast cancer survivor, to match her historic $1 million gift for lobular breast cancer research. Join us in the Match the Million Lobular Breast Cancer Research Challenge! tinyurl.com/LBCAMatchThe...
Join LBCA in Dr. Shannon Klingman's Match the $1 Million Lobular Breast Cancer Research Challenge! tinyurl.com/LBCAMatchThe... #lobularbreastcancer #ILC #invasivelobularcarcinoma #ILCresearch #matchthemillion
